+44 1527 559811
|
FibRestore®
|
Reliv Proven Effective in Clinical Trial
New study shows Reliv Now® and FibRestore® may help with lowering risk factors for cardiovascular disease.
A team of scientists in the Philippines led by Jorge Sison, MD, recently conducted a clinical study to determine the effects of Reliv Now and FibRestore in reducing major risk factors for cardiovascular disease.
The facts:
• Cardiovascular diseases rank number one in causing death globally.
• Lipid abnormalities like high cholesterol, triglycerides, LDL (“bad cholesterol”) and HDL (“good cholesterol”) are major risk factors for cardiovascular disease.
• Soy and fibers have been proven to help improve lipid abnormalities and therefore, benefit health.
The results:
Reliv Now and FibRestore…
• Reduced average cholesterol by 14%
• Reduced average LDL by 18% and 8%, respectively
• Reduced average triglycerides by 1.2% and 12.4%, respectively
• Reduced average uric acid by 10.4% and 16.7%, respectively
• Produced greater reduction in cholesterol and triglycerides among diabetic and/or overweight individuals
To learn more about the study, download the graphic results.
These statements have not been evaluated by the Food and Drug Administration. Reliv products are not intended to diagnose, treat, cure or prevent any disease.